NEW River Pharmaceuticals INC
SEC CIK 1288379 · NRPH · last insider filing 2007-01-31
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Kirk Randal J | Director · Chairman, President and CEO | filed 2006 - 2007 |
| Horner Larry D /FA | Director | filed 2006 - 2007 |
| Sobel Burton E | Director | filed 2006 - 2007 |
| Alvarez Cesar L | Director | filed 2006 - 2007 |
| Krishnan Krish S | Director · COO, CFO and Secretary | filed 2006 - 2007 |
| Krishnan Suma | Director · Vice President, Product Dev. | filed 2006 - 2007 |
| Barlow David S | Director | filed 2006 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Manvelian Garen Z | Chief Medical Officer | filed 2006 - 2006 |
| Roy Samir D | VP Formulation & Manufacturing | filed 2006 - 2006 |
| Thottathil John K | Chief Scientific Officer | filed 2006 - 2006 |
| Colucci Robert D | Vice President,Clinical Devel | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.